U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671755) titled 'Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment' on June 22.
Brief Summary: This study aims to evaluate clinical outcomes of colistin versus colistin in combination with cefoperazone-sulbactam for patients with MDR-AB VAP treatment.
Study Start Date: Feb. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Clinical Response
Radiological Response
Intervention:
DRUG: colistin plus cefoperazone-sulbactam combination group
Combination therapy
DRUG: Colistin
Monotherapy
Recruitment Status: COMPLETED
Sponsor: Shaheed Mohtarma Benazir B...